Digital PNG artwork · delivered by email | Secure checkout · no physical shipping
Hedi Raizer

Journal 7 min read

How does autophagy work?

Autophagy is a conserved lysosomal degradation pathway that recycles cytoplasmic components. This page outlines its core machinery and summarizes recent research on its modulation in viral infection, aging, infertility,

peptides-pro Editorial

How does autophagy work?

Autophagy, formally known as macroautophagy, is a catabolic process in which cytoplasmic material—including damaged organelles, protein aggregates, and invading pathogens—is sequestered into double-membrane vesicles called autophagosomes and delivered to lysosomes for degradation. The term derives from the Greek auto (self) and phagein (to eat). The pathway is conserved from yeast to humans and operates at basal levels in most cells, but is rapidly upregulated by stressors such as nutrient deprivation, hypoxia, and infection. The core machinery comprises a set of autophagy-related (ATG) proteins that orchestrate initiation, nucleation, elongation, and fusion. The initiation complex includes ULK1, ATG13, FIP200, and ATG101; downstream components include the class III PI3K complex (VPS34, Beclin-1, ATG14), the ATG12–ATG5–ATG16L1 conjugate, and the LC3/GABARAP lipidation system. These molecular components have been identified across model organisms, and their functions are the subject of ongoing research.

The pathway is regulated by two major kinase hubs: mTORC1, which suppresses autophagy under nutrient-rich conditions, and AMPK, which activates it during energy stress. The work described below centers on the ATG13-containing ULK1 initiation complex and its crosstalk with innate immune signaling, as well as on broader autophagy-related mechanisms in aging, reproduction, and neurodegeneration.

Research Studies

ATG13 and K63-linked polyubiquitination of MAVS in influenza A virus infection

ATG13 is a regulatory subunit of the ULK1 complex that is essential for autophagy initiation. A study investigating its role during influenza A virus (IAV) infection found that ATG13 restricts IAV replication while enhancing type I interferon (IFN-I) signaling. Coimmunoprecipitation assays showed that ATG13 interacts with MAVS, the mitochondrial antiviral-signaling protein, and recruits the E3 ubiquitin ligase ASB1 to catalyze K63-linked polyubiquitination of MAVS at lysine 348. This modification amplifies the downstream antiviral signaling cascade. The findings identify a non-canonical function for ATG13 in innate immunity, linking the autophagy initiation machinery to MAVS-mediated IFN induction [1].

LSD1-mediated demethylation of ATM in senescence and organ aging

Lysine-specific demethylase 1 (LSD1) was found to be upregulated in aged organs and senescent cells. In response to natural aging or ionizing radiation-induced DNA damage, LSD1 interacts with and demethylates ATM at lysine 3016, a modification that sustains ATM phosphorylation and amplifies DNA damage signaling. This mechanism promotes cellular senescence and organ aging. The study used a newly generated ATM-K3016me antibody to confirm the modification. The work defines a role for LSD1 in DNA damage-mediated senescence and suggests that targeting this axis may influence age-related tissue dysfunction [2].

Natural medicines for Alzheimer's disease: bibliometric and mechanistic insights

A bibliometric analysis and narrative review mapped research trends in natural medicines for Alzheimer's disease (AD) from 2001 to 2025. The analysis identified autophagy modulation as a recurring mechanistic theme among experimental studies. The review synthesized representative evidence on how natural compounds may influence AD-related pathways, including amyloid-beta clearance and tau metabolism. The authors noted that the field remains insufficiently characterized and called for more rigorous experimental validation [3].

Fasting, exercise, and diet to activate autophagy in depression

An ongoing clinical study (NCT07664540) is investigating how lifestyle factors such as physical activity and diet-related processes may influence autophagy and biological mechanisms linked to depression. The study focuses on autophagy as a natural cellular process that helps cells remove damaged components and maintain healthy function. Autophagy is influenced by energy availability and may be affected by behaviors such as exercise and caloric restriction. The trial aims to better understand these relationships in the context of depression, a condition for which current treatments are not universally effective [4].

Astaxanthin and autophagy activation in granulosa cells in PMOS-associated infertility

A triple-blind, placebo-controlled pilot randomized trial evaluated whether astaxanthin (AST) modulates autophagy-related signaling in granulosa cells (GCs) from women with polyendocrine metabolic ovarian syndrome (PMOS), formerly referred to as polycystic ovary syndrome (PCOS). Fifty women with PMOS-related anovulatory infertility were enrolled between November 2023 and September 2024 and received AST (12 mg/day) or placebo. The study assessed autophagy markers in GCs and their relationship to ovarian response. Given the central role of autophagy in follicular development, the trial aimed to clarify whether AST's effects on oxidative stress, endoplasmic reticulum stress, and apoptosis involve autophagy modulation [5].

Fisetin and amyloid-beta-induced neurotoxicity in SH-SY5Y cells

Fisetin, a natural flavonoid with antioxidant properties, was evaluated for neuroprotective effects using in silico target prediction and an in vitro model of amyloid-beta (Aβ1-42)-induced neurotoxicity in human neuroblastoma SH-SY5Y cells. In silico studies indicated that fisetin binds strongly and stably to ULK1 (an autophagy marker), p21 (a senescence/cell cycle marker), and synaptophysin (a synaptic marker). In vitro validation showed that fisetin attenuated Aβ-induced neurotoxicity, with effects on autophagy and senescence pathways. The study provides mechanistic insights but remains limited to cell culture and computational models [6].

Inorganic phosphate and exercise intolerance: a link to autophagy and muscle energetics

A review examined how chronic excess of inorganic phosphate (Pi) from ultra-processed foods may impair skeletal muscle energetics and contribute to exercise intolerance. The modern western diet contains Pi additives that are nearly completely absorbed, leading to habitual intake exceeding recommended levels by two- to three-fold in many populations. Accumulating evidence suggests that this Pi excess may disrupt mitochondrial function and autophagy in skeletal muscle, although the mechanisms are not fully defined. The review highlights a potential link between diet, autophagy, and muscle health [7].

CCT/TRiC and therapy-induced senescence in glioblastoma multiforme

Glioblastoma multiforme (GBM) is the most lethal primary brain tumor. Standard therapies—resection, radiotherapy, and temozolomide—drive many GBM cells into therapy-induced senescence (TIS), characterized by permanent proliferation arrest, high metabolic activity, and the senescence-associated secretory phenotype (SASP). Senescent cells may initially limit growth but can fuel recurrence by altering the microenvironment and promoting immunosuppression and stem-like traits. GBM is also chaperone-dependent, relying on proteostasis networks including the eukaryotic chaperonin CCT/TRiC. The review discusses how CCT/TRiC shapes TIS and may influence autophagy and senescence pathways in GBM [8].

Astrocytic failure in Parkinson's disease: a system-level model

A review synthesized evidence positioning astrocyte dysfunction, or astrocytopathy, as a central driver of Parkinson's disease (PD) pathogenesis. The work frames PD as a multicellular failure of the neuroglial unit rather than a purely neurodegenerative disorder. While the review does not focus exclusively on autophagy, it discusses how impaired astrocytic quality control, including autophagy, may contribute to PD progression. The model suggests that targeting astrocytic dysfunction could offer therapeutic avenues [9].

Autophagy in hypothalamic POMC and AgRP neurons: implications for obesity

A review examined the role of autophagy in hypothalamic pro-opiomelanocortin (POMC) and agouti-related peptide (AgRP) neurons, which regulate appetite and energy balance. Within the arcuate nucleus, autophagy exerts divergent metabolic effects in these two neuronal populations. The review discusses how hypothalamic nutrient sensing, leptin responsiveness, and intracellular quality control are intertwined in obesity. The findings suggest that modulating autophagy in specific neuronal subsets may have therapeutic implications for obesity, though the evidence is largely from animal models [10].

Hepassocin and age-related liver senescence

Hepassocin (HPS), a hepatokine with known hepatoprotective functions, was studied for its role in liver aging. The research reports that HPS prevents age-related liver senescence and facilitates liver regeneration by activating AMPK. The study identifies HPS as a potential molecular regulator of hepatic aging and regeneration, with implications for chronic liver diseases. The mechanisms involve AMPK-dependent pathways, which are known to intersect with autophagy [11].

Radiation-induced atrial fibrillation and cellular senescence

A study investigated the mechanisms by which ionizing radiation increases susceptibility to atrial fibrillation (AF), a complication of thoracic radiotherapy. The research found that radiation-induced AF is driven by cellular senescence via the GATA4–NF-κB pathway. Senolytic therapy with D/Q (dasatinib plus quercetin) rescued the phenotype in preclinical models. The work links DNA damage, senescence, and cardiac dysfunction, and suggests that targeting senescent cells may mitigate radiation-induced heart disease [12].

If you are reading this for personal health reasons

The compounds and mechanisms described on this page are provided for laboratory research purposes only. We do not provide dosing, medical guidance, or health advice. Anyone considering a compound for personal use should consult a licensed clinician.

Sources

WhatsApp